Navigation Links
Data on Xeomin® (incobotulinumtoxinA) in the Treatment of Blepharospasm to be Presented at the 115th Annual Meeting of the American Academy of Ophthalmology
Date:10/25/2011

may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spasticity in children and adults, and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and at lower doses [see Warnings and Precautions (5.1)].CONTRAINDICATIONSXEOMIN is contraindicated in patients with a known hypersensitivity to the active substance botulinum toxin type A or to any of the components in the formulation and in the presence of infection at the proposed injection site(s).

WARNINGS AND PRECAUTIONS

  • The potency units of XEOMIN are not interchangeable with other preparations of botulinum toxin products. Therefore, units of biological activity of XEOMIN cannot be compared to or converted into units of any other botulinum toxin products.

  • Hypersensitivity reactions have been reported with botulinum toxin products (anaphylaxis, serum sickness, urticaria, soft tissue edema, and dyspnea). If serious and/or immediate hypersensitivity reactions occur further injection of XEOMIN should be discontinued and appropriate medical therapy immediately instituted.

  • Treatment with XEOMIN and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowi
    '/>"/>

  • SOURCE Merz Pharmaceuticals
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
    2. Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S.
    3. Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation
    4. Merz Pharmaceuticals Introduces Comprehensive Programs to Provide Patients With Financial Assistance for Xeomin® (incobotulinumtoxinA)
    5. Merz Pharmaceuticals Announces New Centers for Medicare and Medicaid Billing Q-Code for Xeomin® (incobotulinumtoxinA)
    6. New Data On Xeomin® (IncobotulinumtoxinA) To Be Presented At The 15th International Congress Of Parkinsons Disease And Movement Disorders (MDS)
    7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
    8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
    9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
    10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
    11. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/28/2015)... MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX), a ... its President and Chief Executive Officer, David Hansen ... Investor Conference being held at the Luxe Sunset ... on June 1-3, 2015. Mr. Hansen will ... progress made in the last year and plans for ...
    (Date:5/28/2015)... 28, 2015  IGI Laboratories, Inc. (NYSE MKT: IG), ... generic pharmaceutical company, today announced it has submitted its ... Food and Drug Administration (FDA) of 2015, which brings ... at the FDA to twenty-five. Jason ... "Our team continues to execute on the targets we ...
    (Date:5/27/2015)... May 27, 2015 ... the addition of the  "2015 Strategies in ...  report to their offering.      ... to the UK NAT laboratory practice, as ... and technological trends with significant market impact ...
    Breaking Medicine Technology:MabVax Therapeutics Holdings to Present at the 2015 LD Micro Invitational Investor Conference on June 2nd at 4:30 PM EDT 2MabVax Therapeutics Holdings to Present at the 2015 LD Micro Invitational Investor Conference on June 2nd at 4:30 PM EDT 3MabVax Therapeutics Holdings to Present at the 2015 LD Micro Invitational Investor Conference on June 2nd at 4:30 PM EDT 4IGI Laboratories, Inc. Announces Third ANDA Submission Of 2015 2
    ... Reportlinker.com announces that a new market research report ... Drug Delivery in Central Nervous System Diseases - ... The delivery of drugs ... in the treatment of neurological disorders. Drugs may ...
    ... Robbins & Myers, Inc. (NYSE: ... its Romaco businesses to a group of funds led ... investment firm.  Total consideration was approximately euro 65 million ... and euro 4 million of assumed liabilities and is ...
    Cached Medicine Technology:Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 2Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 3Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies 4
    (Date:5/28/2015)... TX (PRWEB) May 28, 2015 Dr. ... cosmetic surgeons , has announced that the new Houston ... The American Association of Accreditation of Ambulatory Surgery Facilities ... surgery center . , According to Dr. Vitenas, ... meeting the standards of a Class C ambulatory surgery ...
    (Date:5/28/2015)... The connected car is gaining more traction with automakers. ... some iteration of a connected offering in the vehicle. ... as the data collected can be used to calculate ... This is the primary reason that 800+ senior figures ... & Exhibition. , Andrew Pym, TU Automotive’s research ...
    (Date:5/28/2015)... Hexagon Geospatial is pleased to announce that ... engineering, spatial data and mapping services, is using Hexagon ... clouds for urban change assessments in Bernalillo County, New ... Spatial Data Division implemented a countywide approach to generating ... by a variety of different digital aerial camera systems, ...
    (Date:5/28/2015)... Mass. (PRWEB) May 28, 2015 ... $17.5 million round of financing led by Cambia ... solutions company dedicated to transforming health care by creating ... largest and most utilized network for exchanging medical imaging, ... growing customer base, increase the breadth of its network ...
    (Date:5/28/2015)... Westport, CT (PRWEB) May 28, 2015 ... mobile monitoring software, announced their partnership with ... their kids’ online activity. The partnership ... programs with WebWatcher’s comprehensive parental monitoring software ... Detective Rich Wistocki, BeSure Consulting's passion is ...
    Breaking Medicine News(10 mins):Health News:Dr. Paul Vitenas’ New Houston Surgery Center Receives AAAASF Accreditation 2Health News:TU-Automotive: North America’s Leading Insurers Head to Chicago as Connected Car Motor Insurance Shifts up a Gear 2Health News:TU-Automotive: North America’s Leading Insurers Head to Chicago as Connected Car Motor Insurance Shifts up a Gear 3Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4Health News:WebWatcher Partners with BeSure Consulting 2Health News:WebWatcher Partners with BeSure Consulting 3
    ... triples following 62-cent increase on cigarettesMINNEAPOLIS, April 23 ... has a lot of Minnesotans trying to quit ... by ClearWay Minnesota(SM), has seen user volumes spike ... nationwide by 62 cents to expand the ...
    ... April 2009 | About 400 cancer therapy ... States) will meet next week in Vienna at an IAEA ... , The three-day International Conference on Advances in Radiation Oncology ... Conference Building M of the Vienna International Center. , ...
    ... Academy presents EyeSmart(TM) Award to Mr. Abram for 30-year ... in office of Rep. Michael E. CapuanoSAN FRANCISCO, April ... that it is presenting its first EyeSmart(TM) ... the PBS series This Old House and ...
    ... as a national model for research training that promotes ... communities in a paper appearing in the April 2009 ... . , The program, based at the UCSF Center ... funded by the National Institutes of Health as the ...
    ... sales in Russia, Brazil, and India will shrink by ... WALTHAM, Mass., April 23 According to Millennium ... markets in Brazil, India, and Russia, the global economic ... markets in these 3 countries in 2009, particularly for ...
    ... of a new menopausal cooling towel , which provides instant relief ... ... April 23, 2009 -- CHILL International, Inc. announces the launch of a ... hot flashes and night sweats . CHILL Cooling Towels are the ...
    Cached Medicine News:Health News:Minnesota Smokers Turning to QUITPLAN(R) Services After Cigarette Tax Hike 2Health News:Minnesota Smokers Turning to QUITPLAN(R) Services After Cigarette Tax Hike 3Health News:IAEA conference to focus on new techniques in cancer treatment 2Health News:American Academy of Ophthalmology Honors PBS Master Carpenter Norm Abram for His Commitment to Eye Safety 2Health News:American Academy of Ophthalmology Honors PBS Master Carpenter Norm Abram for His Commitment to Eye Safety 3Health News:UCSF HIV/AIDS training program successfully promotes diversity 2Health News:UCSF HIV/AIDS training program successfully promotes diversity 3Health News:Emerging Markets for Diagnostic Imaging Systems Hurt by Economic Crisis 2Health News:Chill Cooling Towels Introduces Instant Relief for Hot Flashes and Night Sweats 2Health News:Chill Cooling Towels Introduces Instant Relief for Hot Flashes and Night Sweats 3
    Diamond Reusable Probed work with all ACMI™ instrument inserts. Dual trumpet valves provide smooth, effective fingertip control over suction and irrigation....
    ... Clinicians are demanding smaller, higher ... their clinical and operational challenges. The ... a powerful architecture for superb High ... mobility and ease-of-use; and a versatile ...
    The new PERIMOUNT Magna heart valve (bioprosthesis), with its true supra-annular design, offers optimal hemodynamics and flow characteristics for treatment of aortic heart valve disease....
    ... the world wide sole distributor of CONOR ... conventional drug eluting stents, the CONOR Medsystems ... stent designed to provide advanced drug delivery ... profiles to be tailored to optimize the ...
    Medicine Products: